You have 9 free searches left this month | for more free features.

genomic deletion 11q

Showing 1 - 25 of 1,560

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed Chronic Lymphocytic Leukemia Trial in Ann Arbor (Metformin)

Recruiting
  • Relapsed Chronic Lymphocytic Leukemia
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
May 11, 2022

22Q11 Deletion Syndrome, tACS Trial (at-home tACS using Starstim-Home tES)

Not yet recruiting
  • 22Q11 Deletion Syndrome
  • tACS
  • at-home tACS using Starstim-Home tES
  • (no location specified)
Dec 15, 2022

22Q11 Deletion Syndrome Trial (Aware Program)

Not yet recruiting
  • 22Q11 Deletion Syndrome
  • Aware Program
  • (no location specified)
Apr 28, 2023

22q11 Deletion Syndrome Trial in Philadelphia, Seattle, Toronto (NB-001, Placebo)

Recruiting
  • 22q11 Deletion Syndrome
  • Aurora, Colorado
  • +3 more
Nov 16, 2022

Examining Genetic Factors That Affect Severity of 22q11.2

Recruiting
  • DiGeorge Syndrome
  • 22q11.2 Deletion Syndrome
    • New York, New York
    • +1 more
    Jul 18, 2022

    22q11.2 Deletion Syndrome Trial in Geneva (Concerta)

    Recruiting
    • 22q11.2 Deletion Syndrome
    • Geneva, Switzerland
      Developmental imaging and psychopathology lab
    Mar 29, 2022

    22q11.2 Deletion Syndrome Trial in Geneva (Risperdal, Placebo)

    Terminated
    • 22q11.2 Deletion Syndrome
    • Geneva, Switzerland
      Developmental imaging and psychopathology lab
    Mar 29, 2022

    22Q Deletion Syndrome Trial in Greenville, Brisbane, Melbourne (ZYN002)

    Active, not recruiting
    • 22Q Deletion Syndrome
    • Greenville, South Carolina
    • +2 more
    Apr 20, 2022

    22q11.2 Deletion Syndrome Trial in Philadelphia (NFC-1)

    Completed
    • 22q11.2 Deletion Syndrome
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 24, 2022

    People Who Have Genetic Changes and Features of Autism: Simons

    Recruiting
    • 16P11.2 Deletion Syndrome
    • +184 more
      • New York, New York
      • +1 more
      Jan 6, 2023

      Children at Increased Risk for Scoliosis Development

      Recruiting
      • Adolescent Idiopathic Scoliosis
      • 22q11.2 Deletion Syndrome
      • MRI
      • +2 more
      • Utrecht, Netherlands
        UMC Utrecht
      Jun 20, 2023

      Trisomy 21, 18, 13 and 22q11.2 Deletion Syndrome

      Recruiting
      • Pregnancy
      • cfDNA screening
      • Tuebingen, Germany
        University Hospital Tuebingen, Department of Women's Health
      Jan 11, 2022

      22q11.2 Deletion Syndrome Trial in Lyon (neuropsychological testing, questionnaires and experimental tasks)

      Recruiting
      • 22q11.2 Deletion Syndrome
      • neuropsychological testing, questionnaires and experimental tasks
      • Lyon, Rhone Alpes, France
        Hopital Vinatier
      Jan 26, 2022

      Genetic Modifiers for 22q11.2 Syndrome

      Completed
      • 22q11.2 Deletion Syndrome
      • Observation
      • Syracuse, New York
        VCFS International Center
      Oct 19, 2021

      Advanced Data Analytics in Genetic Conditions

      Not yet recruiting
      • Neurofibromatosis
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder Trial in Canada (Sertraline, Placebo)

        Not yet recruiting
        • Neurodevelopmental Disorders
        • +25 more
        • Calgary, Alberta, Canada
        • +6 more
        Oct 11, 2023

        Prenatal Examination of Deletion 22q11 Syndrome : Thymic

        Completed
        • 22q11 Deletion Syndrome Di George Syndrome
          • Nîmes, France
            CHUNimes
          Jan 26, 2021

          Fragile X Syndrome, Angelman Syndrome, Prader-Willi Syndrome Trial in Research Triangle Park (Parent-Infant Inter(X)action

          Enrolling by invitation
          • Fragile X Syndrome
          • +13 more
          • Parent-Infant Inter(X)action Intervention (PIXI)
          • Research Triangle Park, North Carolina
            RTI International
          Feb 23, 2022

          Non-Invasive Chromosomal Evaluation of 22q11.2

          Completed
          • 22q.11.2 Deletion/Duplication
            • Brussles, Belgium
              The Fetal Medicine Foundation Belgium
            Apr 28, 2020

            NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

            Recruiting
            • Carcinoma, Non-Small-Cell Lung
            • Avitinib Maleate
            • +13 more
            • Guangzhou, Guangdong, China
              Guangdong Lung Cancer Institute, Guangdong Provincial People's H
            Dec 3, 2022

            22q11 Deletion Syndrome, DiGeorge Syndrome, Trisomy 21 Trial in Worldwide

            Completed
            • 22q11 Deletion Syndrome
            • +10 more
              • San Francisco, California
              • +20 more
              Jan 27, 2021

              GROWing Up With Rare GENEtic Syndromes

              Recruiting
              • Prader-Willi Syndrome
              • +32 more
              • Retrospective file studies
              • Rotterdam, Zuid-Holland, Netherlands
                Erasmus Medical Center
              Jul 3, 2020

              Leukemia Trial in Houston (Cyclophosphamide, Rituximab, Sapacitabine)

              Terminated
              • Leukemia
              • Houston, Texas
                University of Texas MD Anderson Cancer Center
              Aug 15, 2019

              Genomic and Dietary Aspects in Gastric Cancer Risk

              Not yet recruiting
              • Gastric Cancer
                • Roma, Italia, Italy
                  Dipartimento Universitario di Scienze della Vita e Sanità Pubbli
                Jun 28, 2023